Lexeo Therapeutics, Inc. (LXEO) Misses Q1 EPS by 10c

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q1 EPS of ($0.99), $0.10 worse than the analyst estimate of ($0.89).

For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.

You May Also Be Interested In

• Cinema United: issues joint letter to state AGs and Paramount
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
• Klarna shares tumble on weak full-year revenue guidance